Pfizer Just Confirmed It's a Dividend Investor's Dream Stock
(NYSE: PFE) has been a nightmare for many investors in recent years. At one point earlier this year, the big pharma stock was nearly 60% below its peak set in late 2021.
However, the narrative for Pfizer appears to be changing. Its shares are up a respectable 9% year to date. The company reported better-than-expected second-quarter results on Tuesday. I think this Q2 update is much more important than only the headline numbers. Here's how Pfizer just confirmed it's a dividend investor's dream stock.
Anyone who has followed Pfizer lately knows it offers a high forward dividend yield of over 5.3%. The drugmaker has increased its dividend for 15 consecutive years. Income investors should love that Pfizer's management appears to solidly support keeping that streak going.
Source Fool.com
Pfizer Inc. Aktie
Die Pfizer Inc. Aktie steht gut da: Deutlich mehr Buy- als Sell-Einschätzungen in der Community.
Das Kursziel von 41 € für Pfizer Inc. impliziert eine deutliche Steigerung um über 50% gegenüber 26.41 €.
